iCliniq Logo
HomeHealth articlesMedical oncologybilateral breast cancer

Bilateral Breast Cancer - Types, Symptoms, Diagnosis, and Treatment

Verified data
0

5 min read

Share

Outline

Bilateral breast cancer is a rare occurrence of breast cancer in females that occurs in both breasts. Read below to know more.

Medically reviewed byDr. Abdul Aziz Khan

Published At March 22, 2023
Reviewed AtDecember 19, 2025

What Is Bilateral Breast Cancer?

Bilateral breast cancer may not be the most common form of breast cancer, but when it occurs, it can be emotionally and medically overwhelming. In simple terms, it means cancer is present in both breasts at the same time (synchronous) or develops in the second breast months or years later (metachronous).

Diagnosis and early detection of bilateral breast cancer is the greatest challenge. Due to the fact that symptoms are either subtle and develop gradually or manifest at various times, most cases are either missed or receive treatment late, resulting in negative outcomes.

Early detection, particularly among high-risk women and the use of better imaging methods, genetic screening, and customized treatment schedules, can greatly enhance survival and quality of life.

The bilateral breast cancer is no longer a medical enigma due to modern oncology. Women are more likely to diagnose the disease at an early stage, get better treatment, and be successful in learning about their responsibility to be in the habit of early self-examination and frequent follow-ups.

What Are the Various Types of Bilateral Breast Cancer?

The following are the various types of bilateral breast cancers:

  • Metachronous Breast Cancer - It is a commonly occurring breast cancer. Most metachronous breast cancers are genetically occurring cancers. They occur at different times in either breast.

  • Synchronous Breast Cancer - It is the most uncommon type of breast cancer and is also known as contralateral breast cancer. It is a cancer in which two or more different tumors are present. It can be invasive or non-invasive. The cause of synchronous breast cancer is unknown. It is to be remembered that both metachronous and synchronous breast cancer are equally deadly.

  • Bilateral Lobular Breast Cancer - Lobular breast cancer occurs in the breast's lobules. Lobules are the glands in the breast that secrete milk. It is an invasive cancer that spreads to the surrounding breast tissue as well as the lymph nodes.

  • Bilateral Intraductal Breast Cancer - Lobules in the breast are all connected through ducts, making a passage for the milk. Cancer occurring in these ducts is called intraductal cancer.

What Are the Symptoms of Bilateral Breast Cancer?

Symptoms are similar to regular breast cancer, but they occur in both breasts. They may include:

  • Lump or swelling in any part of either breast.

  • Thickening or hardening of breast tissue.

  • Skin dimpling that makes the breast look like an orange peel.

  • Pain in the breast or nipple.

  • Nipple turning inward.

  • Red, dry, flaky, or thickened skin over the breast or nipple.

  • Nipple discharge (fluid coming from the nipple).

  • Swelling of lymph nodes near the armpit or collarbone

However, in certain cases, there are no symptoms at all, and cancer is found during routine screening. This is why regular mammograms are very important, especially for women at high risk.

What Are the Risk Factors for Developing Bilateral Breast Cancer?

The causes of risk for bilateral breast cancer remain unknown to date, although some identified risk factors include the following:

  • Heavy alcohol consumption.

  • First diagnosis before the age of 30 years.

  • Inheritance of a BRCA1, BRCA2, or CHEK2 mutation.

  • Family history of breast cancer, especially in first-degree relatives (mother, sister, daughter) and second-degree relatives (grandmother, aunt). A strong family history increases the chances of cancer developing in both breasts.

  • Urban residence.

  • Lobular cancers (where cancer starts in the milk-producing glands), rather than ductal cancers.

  • Cancers that are estrogen receptor-negative (ER-negative).

  • Receipt of scatter radiation.

Some factors that reduce bilateral breast cancer risk are:

  • Trailing at first menarche at age 13 years or more.

  • Having three or more pregnancies.

  • The traditional breast cancer risk factors include smoking cigarettes, hormone replacement therapy, and oral contraceptives, none of which increases the risk for bilateral breast cancer.

How Common Is Bilateral Breast Cancer compared to Unilateral Breast Cancer?

Bilateral breast cancer is a rare finding, yet lethal when compared to unilateral cancer. It can be caused by genetic mutations or exposure to risk factors. The chances of occurrence of bilateral breast cancer in individuals already having breast cancer are higher than in individuals without cancer.

Is There a Metastasis of Bilateral Breast Cancer?

Like other cancers, bilateral breast cancer can spread to other organs, a process known as metastasis. The most common places breast cancer spreads to are the bones, lungs, liver, and brain. In some cases, it can spread to the stomach. When this happens, doctors have to carefully study whether the cancer in the stomach began there or spread from the breast. This is important because treatment changes based on where the cancer started.

How can breast cancer be diagnosed

How Can Breast Cancer Be Diagnosed?

Diagnosing bilateral breast cancer requires several tests.

  1. Doctors often begin with an ultrasound to check the nature of a lump. An ultrasound shows whether the lump is solid or filled with fluid and can detect small calcifications. Mammograms are also widely used.

  1. A screening mammogram is done for women without symptoms to catch cancer early. A diagnostic mammogram is performed when a suspicious change or lump is found. For more detailed images, a breast MRI (magnetic resonance imaging) may be done. This test uses magnetic waves to show hidden or tiny tumors that might not be seen on ultrasound or a mammogram.

  1. To confirm cancer, a test called FNAC (fine needle aspiration cytology) may be done. In this test, a thin needle removes a small sample of cells or fluid, which is studied under a microscope. In most cases, doctors also take a small piece of tissue from the lump for histopathology. This test gives clear information about the type of cancer, how fast it is growing, and whether it can spread.

What Are the Treatment Options for Bilateral Breast Cancer?

Treatment modalities for bilateral breast cancer involve the following approaches:

  • Modified Radical Mastectomy With or Without Lymph Node Dissection - Bilateral breast cancers usually include the adjacent lymph nodes, due to which the resection of lymph nodes along with mastectomy (complete removal of the breast) is performed. In certain cases, lumpectomy is also performed, which is the removal of only the affected tissue of the breast.

  • Chemotherapy - Chemotherapy includes administering anticancer drugs to kill cancer cells.

  • Radiotherapy - The body is exposed to high-dose radiation that directly destroys the cancer cells. Radiation therapy is given to patients at one-month intervals.

  • Adjuvant Therapies - Adjuvant therapies are treatments added after the surgery to obtain a positive treatment outcome. Chemotherapy and radiotherapy are advised to improve the treatment outcome.

What Is the Prognosis for Bilateral Breast Cancer?

The prognosis of bilateral breast cancer is different for every woman. Several factors decide the outcome, such as whether the cancer is synchronous or metachronous, how early it is detected, whether lymph nodes are involved, and what type of tumor is present. Women with synchronous bilateral cancer may have a slightly poorer outcome because the body is fighting two cancers at the same time.

However, outcomes have improved a lot with early detection, better imaging, genetic screening, and modern treatment options. Early screening plays a very important role. Women above the age of 40 should go for routine mammograms. Women with a strong family history or genetic risk may start screening earlier.

Conclusion:

Bilateral breast cancer is a rare but serious form of breast cancer that affects both breasts. It may occur at the same time or at different times. Women with a strong family history and BRCA (breast cancer gene) gene mutations have a higher chance of developing it.

Early diagnosis, undergoing regular mammograms, genetic testing, regular self-examination, and timely treatment improve survival and quality of life. With modern medical advances, personalized treatment, and better awareness, many women manage this condition successfully.

Key Takeaway/Note From iCliniq:

  • Bilateral breast cancer occurs when cancer develops in both breasts, either at the same time or at different times.

  • Family history and BRCA1/BRCA2 gene mutations significantly increase the risk.

  • Diagnosis involves clinical exam, mammography, ultrasound, and breast MRI, which help find tumors in the early stage.

  • Treatment includes surgery, chemotherapy, radiation, hormone or targeted therapy, and genetic counseling for patients and for families at high risk. If concerned, you can ask an oncologist at iCliniq for guidance.

Listen to related tracks in our music library

Frequently Asked Questions

The life expectancy for stage 3 bilateral breast cancer can vary depending on various factors, such as the individual's overall health, the specific characteristics of the cancer, and the effectiveness of the treatments received. Consultations with specialists can be made who can provide detailed information and discuss the outcome based on the patient's situation.
Bilateral breast cancer, which affects both breasts simultaneously or in close succession, is relatively rare compared to unilateral breast cancer. While the exact prevalence may vary, statistics indicate that bilateral breast cancer accounts for a small percentage of breast cancer cases. However, the occurrence of bilateral breast cancer may be influenced by factors such as genetic predisposition, family history, and certain gene mutations. Individuals need to stay vigilant about their breast health and undergo regular screenings, especially if they have risk factors associated with bilateral breast cancer.
The risk of breast cancer in the non-cancerous breast after a bilateral mastectomy is generally low but not completely eliminated. Although a bilateral mastectomy significantly reduces the risk of developing breast cancer in both breasts, there is still a small chance of new breast cancer developing in the remaining breast tissue. The exact risk varies depending on individual factors such as genetic predisposition, hormone receptor status, and other risk factors. Regular surveillance, including clinical exams and imaging studies, is recommended to monitor the non-cancerous breast after a bilateral mastectomy and detect any potential abnormalities early.
The available treatments for breast cancer following a bilateral mastectomy depend on various factors, including the specific characteristics of the cancer, stage, and individual patient considerations. Treatment options may include systemic therapies such as chemotherapy, targeted therapy, or hormonal therapy, depending on the tumor's characteristics. Radiation therapy may also be recommended in certain cases. Additionally, reconstructive surgery options can be discussed with a plastic surgeon to restore the appearance of the breasts. The treatment plan is typically personalized and decided upon through a collaborative effort involving the oncology team and the patient to ensure the most effective and suitable approach.
Stage 3 bilateral breast cancer is considered a serious and advanced stage. At this stage, the cancer has spread to nearby lymph nodes or other tissues near the breasts. The severity of stage 3 bilateral breast cancer is influenced by various factors, including the size and extent of the tumors, the involvement of lymph nodes, and the presence of any distant metastases. The treatment usually involves surgery, radiation therapy, targeted therapy, and hormone therapy. The prognosis and outcomes for stage 3 bilateral breast cancer can vary depending on individual factors.
Bilateral breast cancer refers to breast cancer that affects both breasts simultaneously or sequentially. The most common type of breast cancer that is typically bilateral is invasive ductal carcinoma (IDC). IDC is a type of breast cancer that starts in the milk ducts and can potentially spread to other tissues. However, it is important to note that bilateral breast cancer can involve different types of breast cancer, including invasive lobular carcinoma, mixed ductal and lobular carcinoma, or even different subtypes within the same breast. The specific type of breast cancer in bilateral cases can vary, and accurate diagnosis and staging are essential for effective treatment planning.
The chances of being diagnosed with bilateral breast cancer vary depending on various factors. While bilateral breast cancer is relatively rare compared to unilateral breast cancer, certain risk factors can increase the likelihood of developing it. These risk factors may include a family history of bilateral breast cancer, genetic mutations such as BRCA1 or BRCA2, prior radiation therapy to the chest, and certain syndromes or conditions. Most breast cancer cases are still unilateral. Regular breast self-exams, mammograms, and genetic counseling can help assess individual risk and early detection of potential breast cancer, including bilateral cases.
The likelihood of breast cancer recurrence after a bilateral mastectomy is generally low but not eliminated. Bilateral mastectomy is an effective risk-reducing surgery that removes both breasts to reduce the chances of cancer recurrence. However, there is still a small risk of recurrence due to the possibility of residual cancer cells or metastasis to other areas of the body. The risk factors for recurrence after bilateral mastectomy include the stage and aggressiveness of initial cancer, lymph node involvement, and other individual characteristics. Regular follow-up appointments, surveillance, and ongoing monitoring are important to detect any signs of recurrence early on.
The type of surgery performed for bilateral breast cancer depends on various factors, including the extent and characteristics of the tumors, the individual's overall health, and personal preferences. Treatment options may include a bilateral mastectomy, which involves the removal of both breasts, either with or without breast reconstruction. In some cases, breast-conserving surgery (such as lumpectomy) may be performed if the tumors can be safely removed while preserving breast tissue. The surgical approach is determined through a collaborative decision-making process involving the patient, oncology team, and surgical specialists to ensure the best possible outcomes and meet the individual's treatment goals and preferences.
The most common type of bilateral breast cancer is invasive ductal carcinoma (IDC). IDC is a type of breast cancer that starts in the milk ducts and can potentially spread to other tissues. It accounts for a significant majority of breast cancer cases, both unilateral and bilateral. Lobular and mixed ductal carcinoma can also occur bilaterally but are less common. Accurate diagnosis and staging are crucial in determining the specific type of breast cancer involved in bilateral cases, as treatment plans may vary based on the tumor characteristics.
The survival rate for synchronous bilateral breast cancer, which refers to cancer in both breasts simultaneously, can vary depending on individual factors and the cancer stage. Survival rates are typically influenced by factors such as tumor size, lymph node involvement, cancer grade, and the treatment's effectiveness. It is important to consult with healthcare professionals who can provide personalized information and discuss the prognosis based on the specific characteristics of cancer and individual health factors. Early detection, appropriate treatment, and regular follow-up care can improve the chances of survival for synchronous bilateral breast cancer.
The treatment for bilateral breast cancer depends on several factors, including the stage, size, and characteristics of the tumors and the individual's overall health. The treatment usually consists of surgery, radiation therapy, targeted therapy, and hormonal therapy. The specific treatment plan is determined through a multidisciplinary approach involving oncologists, surgeons, and other healthcare professionals. Treatment aims to eliminate or control the cancer, minimize the risk of recurrence, and improve overall survival. Patients must discuss their treatment options with their physician to develop a specific treatment plan according to their needs and circumstances.
Synchronous bilateral breast cancer refers to the presence of cancer in both breasts simultaneously. It is characterized by the simultaneous development of separate primary tumors in each breast rather than the spread of cancer from one breast to another. Synchronous bilateral breast cancer can present unique challenges in diagnosis and treatment. It requires careful evaluation and staging to determine the extent of the disease in each breast. Treatment options may involve surgery, radiation therapy, chemotherapy, targeted therapy, and hormonal therapy. The treatment plan is tailored to the individual's situation, considering tumor characteristics, overall health, and personal preferences.
Survival rates for bilateral breast cancer can vary depending on various factors, including the cancer stage, tumor characteristics, treatment received, and individual health factors. It is possible to survive bilateral breast cancer, and the prognosis is influenced by early detection, effective treatment, and ongoing monitoring. The survival rate can be improved with timely diagnosis, appropriate surgical intervention, and comprehensive adjuvant therapies such as chemotherapy, radiation, and hormone therapy. Individuals diagnosed with bilateral breast cancer must engage in regular follow-ups to monitor for any signs of recurrence of cancer.
The type of breast cancer most likely to metastasize or spread to other parts of the body is invasive breast cancer. Within invasive breast cancer, certain subtypes have a higher tendency for metastasis. These subtypes include invasive ductal carcinoma (IDC), invasive lobular carcinoma (ILC), and triple-negative breast cancer (TNBC). These subtypes have different biological characteristics that may contribute to their higher likelihood of metastasis. It is important to note that early detection, appropriate treatment, and ongoing monitoring can help manage and potentially prevent metastatic breast cancer. Regular follow-up care and adherence to recommended screenings and surveillance are crucial for monitoring and addressing any potential metastatic spread.
Source Article IclonSourcesSource Article Arrow

Tags:

bilateral breast cancer

Ask your health query to a doctor online

Medical oncology

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.